Hhcefi 50 Dry Syrup contains Cefixime 50mg/5ml, a third-generation cephalosporin antibiotic effective against a broad spectrum of Gram-positive and Gram-negative bacteria. It is indicated for the treatment of various bacterial infections including respiratory tract infections, urinary tract infections, otitis media, pharyngitis, tonsillitis, and uncomplicated gonorrhea. Cefixime acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. The dry syrup formulation is designed for pediatric use, ensuring accurate dosing and improved compliance in children unable to swallow tablets. After reconstitution with the specified volume of water, the suspension should be shaken well before each use. The usual dosage varies according to the severity and type of infection, typically administered twice daily. Hhcefi 50 Dry Syrup is generally well tolerated; however, adverse effects may include gastrointestinal disturbances such as diarrhea, nausea, abdominal pain, and hypersensitivity reactions like rash or pruritus. It is contraindicated in patients with known hypersensitivity to cephalosporins or penicillins. Caution is advised in patients with renal impairment, and dosage adjustments may be necessary. As with all antibiotics, completing the full prescribed course is essential to prevent resistance development. This medication should be stored in a cool, dry place and used within the recommended period after reconstitution.